Philip Morris International Inc (PM) — closed signal from April 21, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 20, 2026.
Predicted vs. what happened
PM price · publication thesis → realized outcomesplit-adjusted
$151.48 – $156.40Entry zone — fair-value band
$155.80Published — price the day we called it
$173.06Target — the price the thesis aimed for
$194.90Peak — highest point inside the window, not a realized return
$192.72Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 20 days.
Peak price
$194.90
peak on July 20, 2026 — not a realized returnPeak gain
+25.1%
peak, from the publication priceWindow close
$192.72
end-of-window price, context onlyDays to target
20
Window
April 21, 2026 – July 20, 2026
The thesis — published April 21, 2026
Predicted growth
+12%
over the measurement windowTarget price
$173.06
the price the thesis aimed forEntry zone
$151.48 – $156.40
the fair-value band we waited forPrice at publication
$155.80
published April 21, 2026Confidence
80%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Philip Morris is a defensive consumer company that may be set up to bounce in the next few months. Interest is focused on IQOS after the FDA renewed its lower-risk claim and favorable brokerage comments. The stock has cooled, so a modest rebound is plausible if earnings back the smoke-free transition story.
Primary drivers
- IQOS progress drives the company's move toward smoke-free products
- FDA renewal strengthens the company's product messaging and positioning
- Positive brokerage notes keep attention on the upcoming earnings window
- A recent price reset has reduced short-term downside risk
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.